Professional
Added to YB: 2024-10-24
Pitch date: 2024-09-30
FRE.DE [bullish]
Fresenius SE & Co. KGaA
+42.38%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients.
Market Cap
EUR 27.2B
Pitch Price
EUR 33.29
Price Target
N/A
Dividend
2.07%
EV/EBITDA
13.54
P/E
24.86
EV/Sales
1.74
Sector
Health Care Providers and Services
Category
value
Show full summary:
Oakmark International Strategy Portfolio Holding: Fresenius SE & Co. KGaA
FRE.DE: Strong Q2 results, esp. Kabi's biosimilars (Tyenne) & Helios' growth in Spain. Mgmt focus on ops execution & portfolio simplification. Attractively valued. Health care services co. w/ leading hospital ops in Europe. Encouraging subsidiary update. Stock rose on positive performance.
Read full article (1 min)